5:00 pm
Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and...
12:00 am
The NIH’s Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) provide up to $1 million over two years for small businesses and research organizations whose work in any biomedical or behavioral research area...
12:00 am
This funding opportunity accepts applications for a Clinical and Translational Science Award (CTSA) Program Data to Health Coordination Center that will support the activities of the CTSA Program in using data to translate discoveries to health...
12:00 am
NCATS will fund up to $400,000 for projects that develop 3D-bioprinted tissue models for drug discovery, including efficacy studies and toxicology research through a collaborative arrangement between the 3-D Bioprinting Program at NCATS and other scientists....
12:00 am
The NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules program supports partnerships between pharmaceutical companies and the biomedical research community to advance therapeutics development. This innovative program matches researchers with pharmaceutical industry resources to test...
12:00 am
Access Pfizer’s drug development expertise, publishing rights and its Centers for Therapeutic Innovation (CTI) foundation partners through research. The CTI and NIH are now accepting proposals for collaborative projects that focus on translational therapeutic drug...
5:00 pm
The NIH’s National Cancer Institute (the NIH is the parent organization of the ITM) will fund $4 million to approximately 10 exploratory projects that develop or validate emerging technologies that contribute to targeting, probing, or...
5:00 pm
The NIH’s National Cancer Institute (the NIH is the parent organization of the ITM) will fund $4 million to approximately 10 exploratory projects focused on the inception and early-stage development of innovative molecular and cellular...
5:00 pm
The National Institute of Mental Health will fund up to $1.75 million per year for applications for Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research. The institute seeks teams of researchers employing...
5:00 pm
The National Cancer Institute will award $400,000 per year for up to five years for projects that develop state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative, multidisciplinary projects that engage the fields of regenerative medicine, tissue...
5:00 pm
NIH’s, the ITM’s parent organization, National Institute on Aging and National Cancer Institute will fund research projects that increase our understanding of the clinical translational potential of metformin to delay aging changes or to extend healthy...
5:00 pm
The NIH’s National Institute on Aging will award $40,000 per year to applications from qualified researchers to acquire training and career development experiences that close expertise gaps in data science and in drug discovery. The goal...
5:00 pm
Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and...
12:00 am
NCATS will fund up to $500,000 per year for projects that support testing new therapeutic uses for experimental drugs across a broad range of pediatric diseases. This innovative program allows investigators to propose new therapeutic uses for...
5:00 pm
The NIH’s National Cancer Institute (the NIH is the parent organization of the ITM) will fund $4 million to approximately 10 exploratory projects that develop or validate emerging technologies that contribute to targeting, probing, or...
5:00 pm
The NIH’s National Cancer Institute (the NIH is the parent organization of the ITM) will fund $4 million to approximately 10 exploratory projects focused on the inception and early-stage development of innovative molecular and cellular...
12:00 am
The NIH’s Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants fund small businesses and research organizations whose work benefits the public. The annual SBIR & STTR Omnibus Solicitation, released by the Department of Health...
12:00 am
The NIH will fund up to $300,000 to projects that support testing new therapeutic uses for experimental drugs across a broad range of human diseases. This innovative program allows investigators to propose new therapeutic uses for...
12:00 am
NCATS will fund up to $500,000 per year for projects that support testing new therapeutic uses for experimental drugs across a broad range of pediatric diseases. This innovative program allows investigators to propose new therapeutic uses for...
5:00 pm
The National Cancer Institute will award $400,000 per year for up to five years for projects that develop state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative, multidisciplinary projects that engage the fields of regenerative medicine, tissue...
5:00 pm
NIH’s, the ITM’s parent organization, National Institute on Aging and National Cancer Institute will fund research projects that increase our understanding of the clinical translational potential of metformin to delay aging changes or to extend healthy...
5:00 pm
The NIH’s National Institute on Aging will award $40,000 per year to applications from qualified researchers to acquire training and career development experiences that close expertise gaps in data science and in drug discovery. The goal...
5:00 pm
Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and...
5:00 pm
Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and...
5:00 pm
The National Institute of Mental Health will fund up to $1.75 million per year for applications for Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research. The institute seeks teams of researchers employing...
5:00 pm
Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and...
5:00 pm
The National Institute of Mental Health will fund up to $1.75 million per year for applications for Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research. The institute seeks teams of researchers employing...
Mar
29
Wed
DEADLINE: Exploratory CTSA Collaborative Innovation Awards (R21) Application
Mar 29 @ 5:00 pm
DEADLINE: Exploratory CTSA Collaborative Innovation Awards (R21) Application

Translating biomedical discoveries into real-world applications is essential to improving human health. It’s a complex process that can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research – and NCATS wants solutions. NCATS’ (the ITM’s parent organization) spurs the development, demonstration, and dissemination of innovations across the translational science spectrum to turn discoveries from the laboratory into tangible benefits to human health. NCATS’s Clinical and Translational Science Award (CTSA) hubs, like the ITM, promote advances in translational research and training at participating institutions.

This funding opportunity funds up to $275,000 to new exploratory and developmental research projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on translational science. This grant will enable collaborative teams of investigators from at least two different CTSA institutions to address translational science questions. Collaborations that bring together approaches from different scientific disciplines are encouraged.

Learn more and submit your application here.

Source: NCATS

Apr
5
Wed
DEADLINE: Small Business Innovation Research & Small Business Technology Transfer Grant Applications
Apr 5 all-day
DEADLINE: Small Business Innovation Research & Small Business Technology Transfer Grant Applications

The NIH’s Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) provide up to $1 million over two years for small businesses and research organizations whose work in any biomedical or behavioral research area falls within the NIH’s mission to improve human health. NCATS small business funding is designed specifically to transform the translational science process so that new treatments and cures for disease can be delivered to patients more efficiently.

Learn more and apply here.

Source: NIH

Apr
14
Fri
DEADLINE: CTSA Program Data to Health (CD2H) Coordinating Center Application
Apr 14 all-day
DEADLINE: CTSA Program Data to Health (CD2H) Coordinating Center Application

This funding opportunity accepts applications for a Clinical and Translational Science Award (CTSA) Program Data to Health Coordination Center that will support the activities of the CTSA Program in using data to translate discoveries to health benefit. It will provide up to $5 million over five years for projects that discover, develop, and disseminate innovation in informatics tools, standards, methods, and processes that will eventually benefit human health.

Learn more and apply here.

Source: NIH NCATS

DEADLINE: NCATS Pilot Program for Collaborative Drug Discovery Research using Bioprinted Skin Tissue Application
Apr 14 all-day
DEADLINE: NCATS Pilot Program for Collaborative Drug Discovery Research using Bioprinted Skin Tissue Application

NCATS will fund up to $400,000 for projects that develop 3D-bioprinted tissue models for drug discovery, including efficacy studies and toxicology research through a collaborative arrangement between the 3-D Bioprinting Program at NCATS and other scientists.

NCATS scientists will provide expertise for 3-D bioprinting, assay development, and drug screening stages of the projects. Other investigators will provide appropriate cell resources, disease expertise, and model validation to perform drug screening of bioprinted materials.

Learn more and submit your application here.

Source: NIH NCATS

Apr
17
Mon
DEADLINE: Discovering New Therapeutic Uses for Existing Molecules Pre-Application
Apr 17 all-day
DEADLINE: Discovering New Therapeutic Uses for Existing Molecules Pre-Application

The NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules program supports partnerships between pharmaceutical companies and the biomedical research community to advance therapeutics development. This innovative program matches researchers with pharmaceutical industry resources to test ideas for new therapeutic uses with the ultimate goal of identifying promising new treatments for patients.

Learn more and apply here.

Source: NIH

Apr
21
Fri
DEADLINE: Pfizer’s Centers for Therapeutic Innovation for NIH Researchers Proposals
Apr 21 all-day

Access Pfizer’s drug development expertise, publishing rights and its Centers for Therapeutic Innovation (CTI) foundation partners through research. The CTI and NIH are now accepting proposals for collaborative projects that focus on translational therapeutic drug targets.

Pfizer’s CTI pairs NIH intramural researchers with Pfizer scientists to pursue scientific and medical advances through joint research and development projects. The CTI model is the first NIH-wide biologics initiative with a pharmaceutical partner that NCATS coordinates on behalf of all NIH intramural researchers. The goal of the program is to identify biologic compounds with activity in a pathway or target of interest to an NIH intramural researcher and to Pfizer. Together, the scientific team works to move these compounds through laboratory testing and into clinical evaluation.

Source: NCATS
Apr
26
Wed
DEADLINE: Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research Letter of Intent
Apr 26 @ 5:00 pm
DEADLINE: Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research Letter of Intent

The NIH’s National Cancer Institute (the NIH is the parent organization of the ITM) will fund $4 million to approximately 10 exploratory projects that develop or validate emerging technologies that contribute to targeting, probing, or assessing molecular and cellular features of cancer biology. Projects should show potential to improve cancer biology research, early detection and screening, clinical diagnosis, treatment, control, epidemiology, and/or address issues associated with cancer health disparities.

Learn more and submit your Letter of Intent.

Source: National Cancer Institute

DEADLINE: Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research Letter of Intent
Apr 26 @ 5:00 pm
DEADLINE: Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research Letter of Intent

The NIH’s National Cancer Institute (the NIH is the parent organization of the ITM) will fund $4 million to approximately 10 exploratory projects focused on the inception and early-stage development of innovative molecular and cellular analysis technologies. Projects should show potential to improve cancer biology research, early detection and screening, clinical diagnosis, treatment, control, epidemiology, and/or address issues associated with cancer health disparities.

Learn more and submit your Letter of Intent.

Source: National Cancer Institute

May
24
Wed
DEADLINE: Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research Application
May 24 @ 5:00 pm
DEADLINE: Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research Application

The National Institute of Mental Health will fund up to $1.75 million per year for applications for Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research. The institute seeks teams of researchers employing integrative, novel, and creative experimental approaches to address high-risk, high-impact questions in basic neuroscience or translational research with the primary objectives of: (a) advancing the state of the science in basic brain and behavior research  that will ultimately provide the foundation for understanding mental disorders; (b) supporting the integration and translation of basic and clinical neuroscience research on severe mental illnesses; and/or (c) advancing our understanding of the neurobehavioral mechanisms that begin in childhood and adolescence.

Learn more and submit your application here.

Source: NIH

Jun
5
Mon
DEADLINE: Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research Application
Jun 5 @ 5:00 pm
DEADLINE: Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research Application

The National Cancer Institute will award $400,000 per year for up to five years for projects that develop state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative, multidisciplinary projects that engage the fields of regenerative medicine, tissue engineering, biomaterials, and bioengineering with cancer biology will be essential for generating novel experimental models that mimic cancer pathophysiology. The projects supported by this FOA will establish and collectively participate in the Cancer Tissue Engineering Collaborative (TEC) Research Program.

Learn more and submit your application here.

Source: NIH